Cargando…

Structure-based virtual screening and molecular docking for the identification of potential multi-targeted inhibitors against breast cancer

Breast cancer is characterized by an uncontrolled growth of cells in breast tissue. Genes that foster cell growth in breast cells are overexpressed, giving rise to breast tumors. The identification of effective inhibitors represents a rational chemopreventive strategy. The current in silico study pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yousuf, Zeeshan, Iman, Kanzal, Iftikhar, Nauman, Mirza, Muhammad Usman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476443/ https://www.ncbi.nlm.nih.gov/pubmed/28652811 http://dx.doi.org/10.2147/BCTT.S132074

Ejemplares similares

Identification of RdRp inhibitors against SARS-CoV-2 through E-pharmacophore-based virtual screening, molecular docking and MD simulations approaches
por: Rehman, Hafiz Muzzammel, et al.
Publicado: (2023)

Virtual screening of RAGE inhibitors using molecular docking
por: Devi Alaparthi, Malini, et al.
Publicado: (2016)

Identification of Inhibitors against Metastasis Protein “Survivin:” In silico Discovery Using Virtual Screening and Molecular Docking Studies
por: Mishra, Swechha, et al.
Publicado: (2017)

Structure-based virtual screening and molecular docking for the identification of potential novel EGFRkinase inhibitors against ovarian cancer
por: Sait, Khalid Hussain Wali, et al.
Publicado: (2019)

Identification of Novel Src Inhibitors: Pharmacophore-Based Virtual Screening, Molecular Docking and Molecular Dynamics Simulations
por: Zhang, Yi, et al.
Publicado: (2020)

The Discovery of Aurora Kinase Inhibitor by Multi-Docking-Based Virtual Screening
por: Kim, Jun-Tae, et al.
Publicado: (2014)

Identification of novel acetylcholinesterase inhibitors designed by pharmacophore-based virtual screening, molecular docking and bioassay
por: Jang, Cheongyun, et al.
Publicado: (2018)

Identification of novel PTPRQ phosphatase inhibitors based on the virtual screening with docking simulations
por: Park, Hwangseo, et al.
Publicado: (2013)

Practical Considerations in Virtual Screening and Molecular Docking
por: Berry, Michael, et al.
Publicado: (2015)

In Silico Core Proteomics and Molecular Docking Approaches for the Identification of Novel Inhibitors against Streptococcus pyogenes
por: Rehman, Abdur, et al.
Publicado: (2021)

Virtual screening based on molecular docking of possible inhibitors of Covid-19 main protease
por: Marinho, Emanuelle Machado, et al.
Publicado: (2020)

Molecular Docking and Virtual Screening of an Influenza Virus Inhibitor That Disrupts Protein–Protein Interactions
por: Ren, Yixin, et al.
Publicado: (2021)

Integrated Computational Approach for Virtual Hit Identification against Ebola Viral Proteins VP35 and VP40
por: Mirza, Muhammad Usman, et al.
Publicado: (2016)

Molecular Docking Based Screening of Plant Flavonoids as Dengue NS1 Inhibitors
por: Qamar, Muhammad Tahir ul, et al.
Publicado: (2014)

Ligand-Based Virtual Screening, Molecular Docking, Molecular Dynamics, and MM-PBSA Calculations towards the Identification of Potential Novel Ricin Inhibitors
por: Botelho, Fernanda D., et al.
Publicado: (2020)

Structure Based Design, Synthesis, Pharmacophore Modeling, Virtual Screening, and Molecular Docking Studies for Identification of Novel Cyclophilin D Inhibitors
por: Valasani, Koteswara Rao, et al.
Publicado: (2014)

Molecular docking study of lamellarin analogues and identification of potential inhibitors of HIV-1 integrase strand transfer complex by virtual screening
por: Eurtivong, Chatchakorn, et al.
Publicado: (2019)

Identification of Potential JNK3 Inhibitors: A Combined Approach Using Molecular Docking and Deep Learning-Based Virtual Screening
por: Yao, Chenpeng, et al.
Publicado: (2023)

Pharmacophore Modeling, Virtual Screening, and Molecular Docking Studies for Discovery of Novel Akt2 Inhibitors
por: Fei, Jia, et al.
Publicado: (2013)

Shape based virtual screening and molecular docking towards designing novel pancreatic lipase inhibitors
por: Veeramachaneni, Ganesh Kumar, et al.
Publicado: (2015)

Discovery of Novel Tankyrase Inhibitors through Molecular Docking-Based Virtual Screening and Molecular Dynamics Simulation Studies
por: Berishvili, Vladimir P., et al.
Publicado: (2020)

A framework and workflow system for virtual screening and molecular docking
por: Schumann, M, et al.
Publicado: (2011)

Identification of STAT1 and STAT3 Specific Inhibitors Using Comparative Virtual Screening and Docking Validation
por: Szelag, Malgorzata, et al.
Publicado: (2015)

Development and Validation of a Docking-Based Virtual Screening Platform for the Identification of New Lactate Dehydrogenase Inhibitors
por: Granchi, Carlotta, et al.
Publicado: (2015)

Identification of novel inhibitors for SARS-CoV-2 as therapeutic options using machine learning-based virtual screening, molecular docking and MD simulation
por: Samad, Abdus, et al.
Publicado: (2023)

Inhibitor designing, virtual screening, and docking studies for methyltransferase: A potential target against dengue virus
por: Singh, Jagbir, et al.
Publicado: (2016)

3D-QSAR-Based Pharmacophore Modeling, Virtual Screening, and Molecular Docking Studies for Identification of Tubulin Inhibitors with Potential Anticancer Activity
por: Mirzaei, Salimeh, et al.
Publicado: (2021)

Identification of natural compounds as SARS-CoV-2 entry inhibitors by molecular docking-based virtual screening with bio-layer interferometry
por: Zhang, Dingqi, et al.
Publicado: (2021)

Identification of novel STAT3 inhibitors for liver fibrosis, using pharmacophore-based virtual screening, molecular docking, and biomolecular dynamics simulations
por: Rafiq, Huma, et al.
Publicado: (2023)

Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer
por: Ganji, Mahmoud, et al.
Publicado: (2023)

Docking and virtual screening of novel inhibitors for mono-ADP-ribosylating toxins
por: Scharfe, M, et al.
Publicado: (2011)

Discovery of YopE Inhibitors by Pharmacophore-Based Virtual Screening and Docking
por: Ozbuyukkaya, Gizem, et al.
Publicado: (2013)

WIDOCK: a reactive docking protocol for virtual screening of covalent inhibitors
por: Scarpino, Andrea, et al.
Publicado: (2021)

The discovery of potential acetylcholinesterase inhibitors: A combination of pharmacophore modeling, virtual screening, and molecular docking studies
por: Lu, Shin-Hua, et al.
Publicado: (2011)

FLT3 inhibitor design using molecular docking based virtual screening for acute myeloid leukemia
por: Gokhale, Padmini, et al.
Publicado: (2019)

Machine Learning Models Combined with Virtual Screening and Molecular Docking to Predict Human Topoisomerase I Inhibitors
por: Li, Bingke, et al.
Publicado: (2019)

Molecular docking based screening of Noggin inhibitors
por: Gudipati, Sindhura, et al.
Publicado: (2018)

Systematic virtual screening in search of SARS CoV-2 inhibitors against spike glycoprotein: pharmacophore screening, molecular docking, ADMET analysis and MD simulations
por: Dhameliya, Tejas M., et al.
Publicado: (2022)

Structure-based virtual screening, in silico docking, ADME properties prediction and molecular dynamics studies for the identification of potential inhibitors against SARS-CoV-2 M(pro)
por: Mohan, Anbuselvam, et al.
Publicado: (2021)

Molecular docking-based computational platform for high-throughput virtual screening
por: Zhang, Baohua, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nu3mh3jrlctmdk2s1r4j3nc76f